产品名称
18:0 PEG350 PE, Avanti Research™ - A Croda Brand 880420P, powder
InChI key
QSUSYAZEVPDIBC-KINGROEASA-N
SMILES string
[H][C@@](COP([O-])(OCCNC(OCCOCCOCCOCCOCCOCCOCCOC)=O)=O)(OC(CCCCCCCCCCCCCCCCC)=O)COC(CCCCCCCCCCCCCCCCC)=O.[NH4+]
assay
>99% (TLC)
form
powder
packaging
pkg of 1 × 25 mg (880420P-25mg), pkg of 1 × 500 mg (880420P-500mg)
manufacturer/tradename
Avanti Research™ - A Croda Brand 880420P
shipped in
dry ice
storage temp.
−20°C
Application
18:0 PEG350 PE is suitable for liposome modification.
Packaging
30 mL Amber Wide Mouth Bottle with Screw Cap (880420P-500mg)
5 mL Clear Glass Sealed Ampule (880420P-25mg)
Legal Information
Avanti Research is a trademark of Avanti Polar Lipids, LLC
存储类别
11 - Combustible Solids
wgk
WGK 3
法规信息
新产品
此项目有
Zebrafish as a predictive screening model to assess macrophage clearance of liposomes in vivo
Sieber S, et al.
Nanomedicine: Nanotechnology, Biology, and Medicine, 17, 82-93 (2019)
Sandro Sieber et al.
Nanomedicine : nanotechnology, biology, and medicine, 17, 82-93 (2019-01-20)
Macrophage recognition of nanoparticles is highly influenced by particle size and surface modification. Due to the lack of appropriate in vivo screening models, it is still challenging and time-consuming to characterize and optimize nanomedicines regarding this undesired clearance mechanism. Therefore
Liming Deng et al.
Biomaterials science, 8(3), 858-870 (2019-12-07)
Hypoxic resistance, photosensitizer toxicity, and target deficiency are major challenges strongly inhibiting the efficacy of clinical photodynamic therapy (PDT) in tumor treatment. To overcome these challenges, we synthesized IR780 and catalase co-loaded liposomes to form a tumor-targeted bio-nanoreactor (LIP-IR-CAT). The
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持